Shirley Ryan AbilityLab
228
37
67
104
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
3.1%
7 terminated/withdrawn out of 228 trials
93.7%
+7.2% vs industry average
3%
7 trials in Phase 3/4
34%
35 of 104 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (228)
Clinical Outcome Assessment for AT & BCI
Role: lead
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
Role: collaborator
Real World Upper Extremity Activity of Stroke Survivors
Role: lead
Development of Low Cost Devices to Increase Access to Treadmill Training
Role: lead
Transcutaneous Spinal Cord Stimulation in Healthy Adults
Role: lead
Impact of Powered Knee-Ankle Prosthesis Leg on Everyday Community Mobility and Social Interaction
Role: lead
tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy
Role: lead
Remote Therapeutic Monitoring Exercise Tracking
Role: lead
Pilot Remote Therapeutic Monitoring in Cancer Patients
Role: lead
Exercise Strategies in Parkinson's Disease
Role: lead
Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy
Role: lead
SIESTA (Sleep of Inpatients: Empower Staff to Act) for Acute Stroke Rehabilitation
Role: collaborator
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
Role: collaborator
Improving Attention in Individuals With Long COVID-19
Role: lead
Altering Activation Patterns Post-stroke
Role: lead
Wearable Sensors to Detect Atypical Muscle Activation in Young Infants
Role: lead
Assessing Upper Extremity Function in Chronic Stroke Survivors Through Acute Intermittent Hypoxia
Role: lead
Resilience in Persons Following Spinal Cord Injury
Role: lead
EMG Training for Altering Activation Patterns After Stroke
Role: lead
Effects of Vibration on Motor Function of Survivors of Chronic Stroke
Role: lead